Oct
2026
Fiera Milano, Italy
Visit us
stand 12A60, Contract Manufacturing & Services
Lyrus Life Sciences
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:India
-
On CPHI since:2019
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 12A60, Contract Manufacturing & Services
Products Featured at CPHI Milan 2026
-
Product Methenamine Hippurate Tabs 1000 mg
Methenamine does not have antibacterial properties in an alkaline environment (pH≥6); however, in a more acidic environment (pH<6), methenamine is hydrolyzed to formaldehyde. Formaldehyde is considered to be highly bactericidal. Formaldehyde has nonspecific antibacterial activity and works by ... -
Product Metformin PR tablets
Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. -
Product Nitrofurantoin Capsules
Nitrofurantoin is reduced by bacterial enzymes to reactive intermediates.These intermediates attack bacterial ribosomal proteins, which stops protein synthesis.This also inhibits the synthesis of DNA, RNA, and cell wall proteins.Nitrofurantoin's broad-based mechanism of action makes it difficult for bacter... -
Product Sucralfate tablets
sucralfate, sold under various brand names, is a medication used to treat stomach ulcers, gastroesophageal reflux disease, radiation proctitis, and stomach inflammation and to prevent stress ulcers. Its usefulness in people infected by H. pylori is limited.
Lyrus Life Sciences Resources (1)
-
Brochure Lyrus Life Science Brochure
Introduction:The Lyrus Life Science brochure provides a comprehensive overview of our company's capabilities, management profile, research and development strengths, and production facilities. It serves as a valuable resource to gain insights into our operations and the therapies we specialize in. At Lyrus Life Science, we are committed to developing innovative products using non-infringing technologies, revolutionizing the healthcare industry.



